Evidence Hub

Formulation, Optimisation, and Characterisation of a Novel Nanoparticle Drug Delivery System for Levofloxacin

Debashish Mohanty

Journal of chemical health risks, 2026

Abstract

The present study was aimed to formulate and characterise levofloxacin-loaded polymeric nanoparticles for improved ocular drug delivery. The nanoparticles were prepared using the oil-in-water (O/W) emulsification solvent evaporation technique, employing polyvinyl alcohol (PVA) as a stabilising agent and poly (lactic-co-glycolic acid) (PLGA) as the polymeric carrier. The developed formulations were evaluated for various physicochemical parameters including particle size, zeta potential, drug loading, encapsulation efficiency, and in vitro drug release. Among all formulations, batch F3 exhibited optimal characteristics with a particle size of 5.62 nm, zeta potential of −18 mV, and high encapsulation efficiency of 96.26%, indicating good stability and efficient drug entrapment. F3 achieved 89.38% drug release at 12 hours and 103.52% at 24 hours, indicating complete and efficient drug release. These findings suggest that the optimised nanoparticle formulation possesses desirable physicochemical properties and sustained drug release behaviour, making it a promising candidate for enhanced ocular delivery of levofloxacin

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free